Wednesday, April 22, 2026

Is A Breakthrough For Thyroid Eye Disease Still Out Of Reach?

HanAll Biopharma's Phase 3 trial of batoclimab for Thyroid Eye Disease failed to show statistical significance, but safety profiles remain consistent.

EU’s New Cyber Law, Adding Security to Tractors for Europe’s $17.7M Fine Threat

Daedong Industrial is developing a security system to comply with the EU's Cyber Resilience Act, enhancing product security in Europe.

China’s Second Man Visits Kim: Was Premier Li Sent to Fix Pyongyang’s Economy

Chinese Premier Li Qiang is set to visit North Korea for the Workers' Party anniversary, enhancing Sino-North Korean relations.

Tag: pharmacokinetic studies

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.